FDA peptides advisory could widen access to unapproved drugs
An FDA advisory supports allowing six unapproved peptide products through compounding pharmacies, prompting debate over safety, evidence and oversight.
FDA proposes GRAS notification rule with streamlined path
FDA’s proposed GRAS notification rule would end self-affirmations, create a streamlined option for legacy ingredients, and likely face legal tests, experts say.
Silver diamine fluoride shown to halt decay in kids
A large U.S. trial finds silver diamine fluoride can stop decay in many baby teeth, offering a low-cost option that may pave the way for FDA approval.